We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$49.9B
AUM Growth
+$3.67B
Cap. Flow
+$2.03B
Cap. Flow %
4.06%
Top 10 Hldgs %
18.48%
Holding
3,585
New
249
Increased
1,827
Reduced
1,181
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 9.37%
2 Financials 8.94%
3 Healthcare 8.86%
4 Industrials 6.89%
5 Communication Services 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
76
Lockheed Martin
LMT
$135B
$132M 0.26%
425,213
+6,916
+2% +$2.06M
BA icon
77
Boeing
BA
$185B
$131M 0.26%
514,304
+7,053
+1% +$1.64M
CVS icon
78
CVS Health
CVS
$134B
$127M 0.26%
1,566,407
+40,272
+3% +$3.19M
BP icon
79
BP
BP
$114B
$126M 0.25%
3,649,266
+190,971
+6% +$6.07M
ABT icon
80
Abbott
ABT
$185B
$125M 0.25%
2,347,721
+56,651
+2% +$2.84M
QCOM icon
81
Qualcomm
QCOM
$159B
$123M 0.25%
2,371,180
-94,738
-4% -$5.01M
APD icon
82
Air Products & Chemicals
APD
$65.2B
$122M 0.24%
804,791
+77,263
+11% +$11.3M
EFA icon
83
iShares MSCI EAFE ETF
EFA
$78.4B
$121M 0.24%
1,763,755
+83,740
+5% +$5.6M
TEL icon
84
TE Connectivity
TEL
$59.8B
$121M 0.24%
1,451,783
+67,329
+5% +$5.41M
AGN
85
DELISTED
Allergan plc
AGN
$120M 0.24%
583,412
-1,214
-0.2% -$282K
AMGN icon
86
Amgen
AMGN
$204B
$117M 0.23%
629,192
+17,619
+3% +$3.12M
SNY icon
87
Sanofi
SNY
$103B
$117M 0.23%
2,346,757
-489,150
-17% -$23.7M
FLRN icon
88
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
$117M 0.23%
3,800,360
+361,678
+11% +$11.1M
PPL
89
PPL Corp
PPL
$26.5B
$117M 0.23%
3,076,564
+45,023
+1% +$1.74M
KHC icon
90
Kraft Heinz
KHC
$31.3B
$116M 0.23%
1,494,894
+76,534
+5% +$6.4M
MMM icon
91
3M
MMM
$91.4B
$115M 0.23%
654,330
-998
-0.2% -$173K
TWX
92
DELISTED
Time Warner Inc
TWX
$114M 0.23%
1,116,134
-21,165
-2% -$2.15M
CCI icon
93
Crown Castle
CCI
$33.6B
$114M 0.23%
1,143,345
+4,396
+0.4% +$450K
WELL icon
94
Welltower
WELL
$168B
$114M 0.23%
1,622,730
-3,091
-0.2% -$225K
SPIB icon
95
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$112M 0.22%
3,242,715
+225,064
+7% +$7.77M
PNC icon
96
PNC Financial Services
PNC
$101B
$109M 0.22%
806,633
+14,769
+2% +$1.9M
USB icon
97
US Bancorp
USB
$99.5B
$109M 0.22%
2,027,843
+86,191
+4% +$4.51M
BIIB icon
98
Biogen
BIIB
$29.7B
$104M 0.21%
332,691
+8,622
+3% +$2.55M
DIS icon
99
Walt Disney
DIS
$170B
$103M 0.21%
1,048,779
-54,314
-5% -$5.59M
C icon
100
Citigroup
C
$224B
$101M 0.2%
1,386,175
+134,843
+11% +$9.21M

Similar funds

Raymond James & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Raymond James & Associates held 3,585 positions worth $49.9B, up 7.9% from $46.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.03B of net new capital in Q3 2017, opening 249 new positions and adding to 1,827 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $61.8M trimmed.

  • Raymond James & Associates's largest Q3 2017 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $261M increase.
  • Raymond James & Associates's biggest Q3 2017 reduction was McDonald's, cutting an estimated $61.8M.
  • Raymond James & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $69.8M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $49.9B portfolio in Q3 2017.
  • Raymond James & Associates opened 249 new positions and closed 188 in Q3 2017.
  • Raymond James & Associates's portfolio value rose 7.9% quarter-over-quarter to $49.9B.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.